SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-24-023696
Filing Date
2024-02-14
Accepted
2024-02-14 16:18:20
Documents
2
Group Members
GARY RIESCHELMARK MCDADEQIMING U.S. HEALTHCARE GP II, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm245867d1_sc13ga.htm SC 13G/A 106535
2 EXHIBIT 99.1 tm245867d1_ex99-1.htm EX-99.1 6939
  Complete submission text file 0001104659-24-023696.txt   115284
Mailing Address 350 106TH AVENUE NE, 1ST FLOOR BELLEVUE WA 98004
Business Address 350 106TH AVENUE NE, 1ST FLOOR BELLEVUE WA 98004 (425) 709-0772
Qiming U.S. Healthcare Fund II, L.P. (Filed by) CIK: 0001765710 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Subject) CIK: 0001788028 (see all company filings)

IRS No.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91228 | Film No.: 24638601
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)